Leucowel 15mg Injection

About

Leucovorin, also known as folinic acid, is a reduced form of folic acid that is metabolically active and does not require reduction by dihydrofolate reductase. This characteristic is crucial in its primary clinical application as a "rescue" agent to mitigate the severe toxic effects of methotrexate, a potent antifolate chemotherapy drug. By providing an exogenous source of reduced folate, leucovorin bypasses the methotrexate-induced inhibition of dihydrofolate reductase, allowing healthy cells to synthesize purines and pyrimidines, thereby protecting them from methotrexate's cytotoxic effects. Additionally, leucovorin is utilized to enhance the cytotoxic activity of fluorouracil in the treatment of certain cancers, particularly colorectal cancer. It achieves this by stabilizing the binding of fluorouracil's active metabolite to thymidylate synthase, thereby prolonging and intensifying the inhibition of DNA synthesis in cancer cells.

Uses

• Methotrexate overdose rescue
• Enhancement of fluorouracil efficacy
• Treatment of megaloblastic anemia due to folate deficiency
• Prevention of pyrimethamine toxicity

Directions For Use

Administer intravenously or orally, as directed by your oncologist, with precise timing relative to other chemotherapy agents.

Benefits

• Reduces methotrexate toxicity
• Improves fluorouracil effectiveness
• Treats specific anemias
• Prevents drug-induced toxicities
• Essential in certain chemotherapy regimens
• Well-established safety profile

Side Effects

• Allergic reactions (rare)
• Fever
• Nausea
• Vomiting
• Diarrhea
• Stomatitis (when used with fluorouracil)
• Rash
• Insomnia
• Agitation
• Seizures (rare, high doses)
• Thrombocytosis (rare)
• Increased toxicity of fluorouracil (if not dosed correctly)

Safety Measures

• Alcohol - No specific interaction with alcohol, but patients undergoing chemotherapy should generally limit or avoid alcohol.
• Pregnancy - Use only if clearly indicated and benefits outweigh potential risks, especially when used with other cytotoxic agents.
• Breastfeeding - Caution advised; consult a doctor. It is generally recommended to avoid breastfeeding during chemotherapy.
• Liver - Use with caution in patients with severe liver impairment, especially when used with other hepatotoxic drugs.
• Kidney - Dose adjustment may be necessary in patients with severe renal impairment, particularly when used for methotrexate rescue.
• Lung - No direct adverse effects on lung function; however, monitor for pulmonary toxicity if used with other agents known to cause lung issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.